EFTHEMIA STAMEY: Open Payments
NPI 1487494118 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,746 in 63 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $272 · 2025 $1,746
Food & beverage: $1,628Education: $117
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $245 |
| Regeneron Healthcare Solutions, Inc. | 6 | $234 |
| Axsome Therapeutics, Inc. | 6 | $217 |
| Inspire Medical Systems, Inc. | 2 | $123 |
| GENZYME CORPORATION | 4 | $116 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Viatris Specialty LLC | 5 | $92 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $90 |
| United Therapeutics Corporation | 3 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $66 |
Products named: DUPIXENT, Sunosi, INSPIRE, YUPELRI, LUMRYZ, GLASSIA, TEZSPIRE, BREZTRI.
Industry payments across SC — which companies pay providers there.
